There is no evidence that post-mortem samples were taken from a premature baby after his death, a hospital boss has said.
There is no evidence that post-mortem samples were taken from a premature baby after his death, a hospital boss has said.
Bonus Biogroup has received FDA approval for an IND application to conduct a Phase III clinical trial of a drug designed to treat acute respiratory distress syndrome (ARDS), especially in severe COVID ...